US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment - Reuters
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Researchers have developed a new approach to prevent brain damage from Alzheimer's by blocking immune cells that harm ne…
A comic artist learned valuable lessons about patience, trust, and friendship during her first backpacking trip. She cre…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →